London Stock Exchange · AZN
AstraZeneca PLC price
Price history, key statistics, and comparable assets for AstraZeneca PLC.
£118.96
+0.39% (£0.4600)
Historical prices
Price history
Intraday through long-term closing prices. Choose 1 day, 1 week, 1 month, 6 months, year to date, 1 year, 5 years, or all available history.
Point-in-time fields
Key statistics
- Previous close
- £118.50
- Open
- £118.98
- Day range
- £118.54 to £120.96
- 52-week range
- £98.92 to £157.32
- Volume
- 11.25m
- Average volume
- 5.75m
- Market cap
- 184.49bn
- P/E ratio (TTM)
- 23.87
Profile
About AstraZeneca PLC
AstraZeneca PLC trades on London Stock Exchange under AZN and is grouped under Health Technology. Figures marked unavailable are not estimated.
Editorial profile
AstraZeneca PLC overview
AstraZeneca PLC researches, develops, manufactures, and markets prescription medicines. Its principal therapy areas are Oncology, BioPharmaceuticals, and Rare Disease, with products used in respiratory, cardiovascular, renal, metabolic, immunology, and other care. These activities place the company in Health Technology and connect AZN to the specific products, services, customers, and operating assets described in its official materials.
SourcesAstraZeneca PLCAZN is the ordinary share quoted on London Stock Exchange. AstraZeneca PLC's investor materials publish annual and interim results, with other updates as scheduled. This profile refers to that local security and operating group, which matters when an issuer has several venues, share classes, depositary receipts, or a name that resembles another company.
SourcesAstraZeneca PLCAstraZeneca PLCA genuinely distinguishing feature is that AstraZeneca combines a broad oncology portfolio with Alexion's rare-disease medicines and complement-biology capabilities. The group conducts discovery through global clinical development and commercial supply. This is more precise than a broad sector label: it identifies a named platform, product architecture, network, asset base, or corporate structure that separates AstraZeneca PLC from otherwise similar issuers.
SourcesAstraZeneca PLC- Security type
- Ordinary Share
Primary sources
- AstraZeneca PLC official company profileAstraZeneca PLC · Retrieved 2026-08-10
- AstraZeneca PLC investor relationsAstraZeneca PLC · Retrieved 2026-08-10
- AZN listing informationAstraZeneca PLC · Retrieved 2026-08-10
Contextual peers
Related assets
Same sector: Health Technology
Same market: United Kingdom
AZN questions
AstraZeneca PLC questions
What business does AZN represent?
AZN represents AstraZeneca PLC, which researches, develops, manufactures, and markets prescription medicines. Its principal therapy areas are Oncology, BioPharmaceuticals, and Rare Disease, with products used in respiratory, cardiovascular, renal, metabolic, immunology, and other care.
Which products, services, or operating markets are specifically associated with AZN?
Its principal therapy areas are Oncology, BioPharmaceuticals, and Rare Disease, with products used in respiratory, cardiovascular, renal, metabolic, immunology, and other care.
What specifically distinguishes the business behind AZN?
For AstraZeneca PLC, the asset-specific distinction is that AstraZeneca combines a broad oncology portfolio with Alexion's rare-disease medicines and complement-biology capabilities. The group conducts discovery through global clinical development and commercial supply.
Risk and data disclosure
Read before using this data
Glide provides this market data for informational purposes only. It is not investment advice, a recommendation, or an offer to buy or sell any asset. Prices may be delayed or incomplete. Verify market data and consider your objectives, financial situation, and professional advice before acting.